Concourse Financial Group Securities’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-27,951
| Closed | -$1.91M | – | 665 |
|
|
2024
Q4 | $1.91M | Buy |
27,951
+2,650
| +10% | +$181K | 0.11% | 193 |
|
|
2024
Q3 | $1.97M | Buy |
25,301
+4,258
| +20% | +$332K | 0.12% | 178 |
|
|
2024
Q2 | $1.64M | Buy |
21,043
+1,308
| +7% | +$102K | 0.1% | 204 |
|
|
2024
Q1 | $1.34M | Buy |
19,735
+916
| +5% | +$62.1K | 0.09% | 235 |
|
|
2023
Q4 | $1.27M | Buy |
18,819
+7,063
| +60% | +$476K | 0.09% | 226 |
|
|
2023
Q3 | $796K | Sell |
11,756
-306
| -3% | -$20.7K | 0.06% | 314 |
|
|
2023
Q2 | $863K | Buy |
12,062
+833
| +7% | +$59.6K | 0.07% | 307 |
|
|
2023
Q1 | $779K | Buy |
11,229
+9,997
| +811% | +$694K | 0.06% | 324 |
|
|
2022
Q4 | $83.5K | Buy |
1,232
+10
| +0.8% | +$678 | 0.01% | 890 |
|
|
2022
Q3 | $67K | Buy |
1,222
+16
| +1% | +$877 | 0.01% | 850 |
|
|
2022
Q2 | $80K | Sell |
1,206
-353
| -23% | -$23.4K | 0.01% | 900 |
|
|
2022
Q1 | $104K | Sell |
1,559
-2,598
| -62% | -$173K | 0.01% | 843 |
|
|
2021
Q4 | $242K | Buy |
4,157
+76
| +2% | +$4.42K | 0.01% | 663 |
|
|
2021
Q3 | $245K | Buy |
4,081
+222
| +6% | +$13.3K | 0.02% | 650 |
|
|
2021
Q2 | $231K | Sell |
3,859
-168
| -4% | -$10.1K | 0.01% | 667 |
|
|
2021
Q1 | $200K | Buy |
4,027
+3,130
| +349% | +$155K | 0.01% | 687 |
|
|
2020
Q4 | $45K | Sell |
897
-65
| -7% | -$3.26K | ﹤0.01% | 1181 |
|
|
2020
Q3 | $53K | Buy |
962
+34
| +4% | +$1.87K | ﹤0.01% | 1033 |
|
|
2020
Q2 | $49K | Buy |
928
+53
| +6% | +$2.8K | ﹤0.01% | 995 |
|
|
2020
Q1 | $39K | Buy |
+875
| New | +$39K | ﹤0.01% | 998 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 2368 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 2068 |
|
|
2019
Q2 | – | Sell |
-1,961
| Closed | -$79K | – | 2488 |
|
|
2019
Q1 | $79K | Buy |
1,961
+223
| +13% | +$8.98K | 0.01% | 736 |
|
|
2018
Q4 | $66K | Buy |
1,738
+560
| +48% | +$21.3K | 0.01% | 727 |
|
|
2018
Q3 | $47K | Buy |
+1,178
| New | +$47K | 0.01% | 606 |
|